Amylyx Pharmaceuticals, Inc. (AMLX) › EPS (Basic)Amylyx Pharmaceuticals, Inc. (AMLX) — EPS (Basic)Annual figures by period end, from SEC filings.2021-12-31: $-13.352022-12-31: $-3.392023-12-31: $0.732024-12-31: $-4.432025-12-31: $-1.53$-1.532021-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-1.53—2026-03-03From 2025-01-012024-12-31$-4.43-706.8%2026-03-03From 2024-01-012023-12-31$0.73—2025-03-04From 2023-01-012022-12-31$-3.39—2024-02-22From 2022-01-012021-12-31$-13.35—2024-02-22From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares